The Cluster ion spectrometry (CIS) experiment
…, J Cuvilo, C Martz, JL Médale, H Perrier… - The cluster and phoenix …, 1997 - Springer
… The time resolution of the instrument is sufficiently high to follow density or flux oscillations
at the gyrofrequency of H+ ions in a magnetic field of 10 nT or less. Such field strengths will be …
at the gyrofrequency of H+ ions in a magnetic field of 10 nT or less. Such field strengths will be …
First multispacecraft ion measurements in and near the Earth's magnetosphere with the identical Cluster ion spectrometry (CIS) experiment
…, JL Medale, E Penou, H Perrier… - Annales …, 2001 - angeo.copernicus.org
On board the four Cluster spacecraft, the Cluster Ion Spectrometry (CIS) experiment measures
the full, three-dimensional ion distribution of the major magnetospheric ions (H + , He + , …
the full, three-dimensional ion distribution of the major magnetospheric ions (H + , He + , …
Fine-needle aspiration cytology guided by endoscopic ultrasonography: results in 141 patients
M Giovannini, JF Seitz, G Monges, H Perrier… - …, 1995 - thieme-connect.com
Background and Study Aims: Diagnosis of submucosal lesions, pancreatic tumors, and
mediastinal or celiac lymph nodes or masses is possible using endoscopic ultrasonography (EUS…
mediastinal or celiac lymph nodes or masses is possible using endoscopic ultrasonography (EUS…
The discovery of rofecoxib,[MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2 (5H)-furanone], an orally active cyclooxygenase-2 inhibitor
…, GP O'Neill, M Ouellet, MD Percival, H Perrier… - Bioorganic & medicinal …, 1999 - Elsevier
… For example, 3, (X = 4-fluorine, entry a, Table 2), is more potent in the COX-1 assay than
entry b (X = H). This is generally true for other para-substituents such as halogens, methyl …
entry b (X = H). This is generally true for other para-substituents such as halogens, methyl …
Slow-and tight-binding inhibitors of the 85-kDa human phospholipase A2
…, F Laliberte, F Ghomashchi, Z Wang, H Perrier… - Biochemistry, 1993 - ACS Publications
Revised Manuscript Received April 1, 1993 abstract: A trifluoromethyl ketone analogue of
arachidonic acid in which the COOH group is replaced with COCF3 (AACOCF3) was prepared …
arachidonic acid in which the COOH group is replaced with COCF3 (AACOCF3) was prepared …
Rofecoxib [Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and …
…, M Ouellet, D Patrick, MD Percival, H Perrier… - … of Pharmacology and …, 1999 - ASPET
The discoveries that cyclooxygenase (COX)-2 is an inducible form of COX involved in
inflammation and that COX-1 is the major isoform responsible for the production of prostaglandins (…
inflammation and that COX-1 is the major isoform responsible for the production of prostaglandins (…
[HTML][HTML] Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment …
…, F Meniai, C Peres, A Esparcieux, H Perrier… - European Journal of …, 2020 - Elsevier
Background Cancer patients are thought to have an increased risk of developing severe
Coronavirus Disease 2019 (COVID-19) infection and of dying from the disease. In this work, …
Coronavirus Disease 2019 (COVID-19) infection and of dying from the disease. In this work, …
[HTML][HTML] BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced …
…, M Gilabert, E François, L Dahan, H Perrier… - Annals of oncology, 2012 - Elsevier
Background Sorafenib is an oral anticancer agent targeting Ras-dependent signaling and
angiogenic pathways. A phase I trial demonstrated that the combination of gemcitabine and …
angiogenic pathways. A phase I trial demonstrated that the combination of gemcitabine and …
5‐lipoxygenase‐activating protein is an arachidonate binding protein
…, ME Cox, E Wong, S Charleson, H Perrier… - FEBS …, 1993 - Wiley Online Library
… rvFLAP600-9 for 48 h. FLAP was undetectable in the 100,000 xg supernatant fraction of
infected cells, suggesting that the protein is efficiently transferred to a membrane fraction when …
infected cells, suggesting that the protein is efficiently transferred to a membrane fraction when …
[HTML][HTML] Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus …
…, H Naman, P Nouyrigat, S Oziel-Taieb, H Perrier… - Annals of oncology, 2013 - Elsevier
Background ML18147 evaluated continued bevacizumab with second-line chemotherapy
for patients with metastatic colorectal cancer (mCRC) progressing after the standard first-line …
for patients with metastatic colorectal cancer (mCRC) progressing after the standard first-line …